| Authors: |
Ross A; Deloitte Consulting LLP, Arlington, VA 22209, USA., Meacham PJ; Deloitte Consulting LLP, Arlington, VA 22209, USA., Waswa JP; USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala 920102, Uganda., Joshi MP; USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Arlington, VA 22203, USA., Hafner T; USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Arlington, VA 22203, USA., Godby S; Deloitte Consulting LLP, Arlington, VA 22209, USA., Johnson C; Deloitte Consulting LLP, Arlington, VA 22209, USA., Londhe S; Deloitte Consulting LLP, Arlington, VA 22209, USA., Aibo D; USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala 920102, Uganda., Kwikiriza G; USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala 920102, Uganda., Kasujja H; USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala 920102, Uganda., Kiggundu R; USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala 920102, Uganda., Cho M; Deloitte Consulting LLP, Arlington, VA 22209, USA., Kovar S; Deloitte Consulting LLP, Arlington, VA 22209, USA., Kitutu FE; Department of Pharmacy, School of Health Sciences, Makerere University, Kampala 920102, Uganda.; Antimicrobial Stewardship, Optimal Access and Use (ASO) Technical Working Committee, National One Health Platform, Kampala 920102, Uganda. |